Misleading Consumers About Electroshock “Side Effects,” Negating How ECT Harms Lives

People in need of help are being consistently put at risk by the treatments the Food and Drug Administration (FDA) approves and by researchers and practitioners in the mental health system recommending them, including antidepressants and electroshock. The misleading information given consumers should be investigated, especially when marketed as being prescribed for “treatment resistance,” a … Read moreMisleading Consumers About Electroshock “Side Effects,” Negating How ECT Harms Lives

Consumers Betrayed: Electroshock Inflicts Pain

Excerpted from information booklet written for CCHR: ELECTROSHOCK – PAIN AND FRAUD IN THE NAME OF THERAPY   Why is electroshock (ECT) continually dogged by controversy? Why is it that women, the frail elderly and children are psychiatry’s main targets for ECT? Where is the true weight of public and scientific opinion? Who profits from ECT? … Read moreConsumers Betrayed: Electroshock Inflicts Pain

Psychiatrists Dismiss Patient Evidence Against ECT as “Anecdotal” to Protect Profits

In 2015, the U.S. Food and Drug Administration issued its “Neurological Devices; Reclassification of Electroconvulsive Therapy Devices Intended for Use in Treating,” recommending that the ECT device be rated Class II (less risk classification than its current Class III) for: Severe major depressive episode (MDE) associated with major depressive disorder (MDD) or bipolar disorder (BPD) … Read morePsychiatrists Dismiss Patient Evidence Against ECT as “Anecdotal” to Protect Profits